Benzinga | Nov 5, 2020 04:08PM EST

Acceleron Pharma Q3 EPS $(0.66) Misses $(0.61) Estimate, Sales $22.56M Miss $26.27M Estimate

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.61) by 8.2 percent. This is a 23.26 percent increase over losses of $(0.86) per share from the same period last year. The company reported quarterly sales of $22.56 million which missed the analyst consensus estimate of $26.27 million by 14.12 percent. This is a 436.15 percent increase over sales of $4.21 million the same period last year.